| 3种药物治疗老年人严重肺部感染的药物经济学分析 |
| 投稿时间：2003-08-29 点此下载全文 |
| 引用本文：劳国琴,唐志华,徐雯宇.3种药物治疗老年人严重肺部感染的药物经济学分析[J].药学实践杂志,2004,(2):106~107 |
| 摘要点击次数: 1313 |
| 全文下载次数: 855 |
|
|
| 中文摘要:目的 探讨3种药物治疗老年人严重肺部感染的经济学效果。方法 选用文献治疗老年人严重肺部感染的3种药物治疗方案(A-头孢哌酮/舒巴坦、B-亚胺培南/西司他丁与C-头孢他啶),运用费用-效果分析方法进行评价。结果 C方案是治疗老年人严重肺部感染的3种药物治疗方案的最佳方案。结论 费用-效果分析方法在优化治疗方案,指导经济、合理用药等方面有着重要作用。 |
| 中文关键词:费用-效果分析 药物经济学 肺部感染 头孢哌酮/舒巴坦 亚胺培南/西司他丁 头孢他啶 |
| |
| Pharmacoeconomics analysis of 3 drugs in the treatment of lower respiratory tract infections in the elderly |
|
|
| Abstract:Objective To evaluate the economic effectiveness of 3 therapeutic schemes for lower respiratory tract infection in the elderly. Methods Three schemes of the treatment of lower respiratory tract infection in the elderly from literatrure cefoperazone/sulbactam(A), imipenem/cilastatin(B), ceftazidime(C) were selected. Data was evaluated using the pharmacoeconomic cost-effectiveness analysis. Results According to the evaluation by cost-effectiveness analysis, C was the best scheme. Conclusion The cost-effectiveness analysis is very important in optimizing therapeutic scheme, guiding rational drug use and increasing economic effectiveness. |
| keywords:cost-effectiveness analysis pharmacoeconomics pulmonary infection cefoperazone/sulbactam imipenem/cilastatin ceftazidime |
| 查看全文 查看/发表评论 下载PDF阅读器 |
|
| 关闭 |
